Integrin β4, relying on the regulation of TNFAIP2 and IQGAP1, effectively activated RAC1, promoting the migration of TNBC cells while enhancing the resistance of cancer cells to DNA damage-related therapies [30]. This evidence concerns the gene RAC1 and cancer.